These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 7790262

  • 41. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H.
    Int J Radiat Oncol Biol Phys; 1998 Mar 15; 40(5):1049-59. PubMed ID: 9539559
    [Abstract] [Full Text] [Related]

  • 42. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
    Vermund H, Pories WJ, Hillard J, Wiley AL, Youngblood R.
    Acta Oncol; 2001 Mar 15; 40(5):558-65. PubMed ID: 11669326
    [Abstract] [Full Text] [Related]

  • 43. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
    Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):735-43. PubMed ID: 17980502
    [Abstract] [Full Text] [Related]

  • 44. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
    Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE.
    J Clin Oncol; 1996 Jan 01; 14(1):156-63. PubMed ID: 8558191
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Multimodal treatment strategy for clinical T3 thoracic esophageal cancer.
    Saeki H, Morita M, Tsuda Y, Hidaka G, Kasagi Y, Kawano H, Otsu H, Ando K, Kimura Y, Oki E, Kusumoto T, Maehara Y.
    Ann Surg Oncol; 2013 Dec 01; 20(13):4267-73. PubMed ID: 23943036
    [Abstract] [Full Text] [Related]

  • 47. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
    Turrini O, Ychou M, Moureau-Zabotto L, Rouanet P, Giovannini M, Moutardier V, Azria D, Delpero JR, Viret F.
    Eur J Surg Oncol; 2010 Oct 01; 36(10):987-92. PubMed ID: 20828979
    [Abstract] [Full Text] [Related]

  • 48. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study.
    Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J, Pisansky TM, Willett CG, Hoffman JP, Owen JB, Hanks GE.
    J Clin Oncol; 2000 Feb 01; 18(3):455-62. PubMed ID: 10653860
    [Abstract] [Full Text] [Related]

  • 49. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA, Greco FA, Gray JR, Thomas M, Sutton VM, Davis JL, Kalman LA, Shaffer DW, Yost K, Rinaldi DA, Hainsworth JD.
    Cancer J; 2003 Feb 01; 9(4):251-60. PubMed ID: 12967135
    [Abstract] [Full Text] [Related]

  • 50. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G.
    Int J Radiat Oncol Biol Phys; 1994 Aug 30; 30(1):161-7. PubMed ID: 8083109
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction.
    Sauter ER, Coia LR, Keller SM.
    Ann Surg Oncol; 1994 Jan 30; 1(1):5-10. PubMed ID: 7834428
    [Abstract] [Full Text] [Related]

  • 56. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma?
    Chan A, Wong A.
    Int J Radiat Oncol Biol Phys; 1999 Sep 01; 45(2):265-70. PubMed ID: 10487544
    [Abstract] [Full Text] [Related]

  • 57. Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer.
    Kim JH, Choi EK, Kim SB, Park SI, Kim DK, Song HY, Jung HY, Min YI.
    Int J Radiat Oncol Biol Phys; 2001 May 01; 50(1):1-12. PubMed ID: 11316540
    [Abstract] [Full Text] [Related]

  • 58. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study.
    De Vita F, Di Martino N, Orditura M, Cosenza A, Galizia G, Del Genio A, Catalano G.
    Chest; 2002 Oct 01; 122(4):1302-8. PubMed ID: 12377857
    [Abstract] [Full Text] [Related]

  • 59. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.
    Swisher SG, Moughan J, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG.
    J Thorac Oncol; 2017 Feb 01; 12(2):368-374. PubMed ID: 27729298
    [Abstract] [Full Text] [Related]

  • 60. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
    Burmeister BH, Denham JW, O'Brien M, Jamieson GG, Gill PG, Devitt P, Yeoh E, Hamilton CS, Ackland SP, Lamb DS.
    Int J Radiat Oncol Biol Phys; 1995 Jul 15; 32(4):997-1006. PubMed ID: 7607974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.